Jay Hancock, Kaiser Health News

Stay informed with Jay Hancock, Kaiser Health News’s coverage and analysis for Fortune.

  • 23 January 2021, Berlin: Pfizer’s logo is displayed at one of its corporate offices. Since 2020, Pfizer has been working with the company Biontech on the development of a Covid 19 vaccine. Photo: Christophe Gateau/dpa (Photo by Christophe Gateau/picture alliance via Getty Images)Health

    Pfizer court fight could legalize Medicare copays and unleash ‘gold rush’ in sales

    By
  • Pamela Valfer, an art professor in Pasadena, California, went to state-run covid testing facilities where she was surprised to find a private lab charging her insurer $250 per test. (Heidi de Marco/KHN)Health

    Hospitals are charging hundreds per COVID test. Will insurance premiums rise to compensate?

    By Hannah Norman and Jay Hancock, Kaiser Health News
  • Oxford-Vaccine-Trials-Kaiser-Health-NewsHealth

    Oxford’s COVID vaccine deal with AstraZeneca raises concerns about access and pricing

    By
  • Insulin used for NovoRapid, an injectable diabetes treatment sold by Novo Nordisk.Health

    How High Drug Prices and Big Lobbying Budgets Go Together for Big Pharma

    By Elizabeth Lucas, Jay Hancock, Kaiser Health News, and others